Adicet Bio, Inc. (ACET) vs Cingulate Inc. (CING)
A side-by-side comparison of Adicet Bio, Inc. and Cingulate Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACET
Adicet Bio, Inc.
$6.46HealthcareDelayed quote: Oct 6, 2026, 10:03 AM EDT
CING
Cingulate Inc.
$4.83HealthcareDelayed quote: Oct 6, 2026, 10:03 AM EDT
Total return — ACET vs CING
growth of $100 · dividends reinvested · last 5yACET -97.0% (-50.5%/yr)CING -99.6% (-66.1%/yr)ACET compounded faster over this window
Log scale — wide-divergence pair
ACET CING
ACET vs CING: by the numbers
- •CING is the larger company ($65M vs $60M market cap).
Metrics side by side
Valuation
| Metric | ACET | CING |
|---|---|---|
| P/B ratio | 0.50 | 2.77 |
| EV / EBITDA | N/A | 0.22 |
Profitability
| Metric | ACET | CING |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -82.38% | -122.71% |
| ROIC | -79.68% | -83.74% |
Growth (annualized)
| Metric | ACET | CING |
|---|---|---|
| Total return CAGR (5Y) | -44.24% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.